VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY
Statin intake is a standard in the treatment of patients with atherosclerosis nowadays. These drugs therapy associates with 30% risk reduction in mortality and coronary events. However , the threat of recurrent events is sufficiently high in large part of patients. This can be related to low level o...
Saved in:
| Main Authors: | E. P. Trukhacheva, M. V. Ezhov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/811 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01) -
Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01) -
Lipoprotein(a) and panvascular disease
by: Ruiyan Xu, et al.
Published: (2025-05-01) -
Atractylenolide I Inhibits Nicotine-Induced Macrophage Pyroptosis and Alleviates Atherogenesis by Suppressing the TLR4/ROS/TXNIP/NLRP3 Pathway
by: Huan-Huan Li, et al.
Published: (2025-05-01) -
Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
by: Hesham Sheashaa, et al.
Published: (2025-01-01)